Search

Your search keyword '"Mak, Tze-Minn"' showing total 137 results

Search Constraints

Start Over You searched for: Author "Mak, Tze-Minn" Remove constraint Author: "Mak, Tze-Minn"
137 results on '"Mak, Tze-Minn"'

Search Results

1. Pathogen genomic surveillance status among lower resource settings in Asia

2. Advancing pathogen genomics in resource-limited settings

3. Impact of Delta Variant and Vaccination on SARS-CoV-2 Secondary Attack Rate Among Household Close Contacts

4. Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study

5. Imported Monkeypox, Singapore

6. Burden and Cost of Hospitalization for Respiratory Syncytial Virus in Young Children, Singapore

7. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study

10. Erratum to “Impact of delta variant and vaccination on SARS-CoV-2 secondary attack rate among household close contacts” [The Lancet Regional Health – Western Pacific 17 (2021) 100299]

14. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Pediatric Age on Delta Variant Household Transmission

15. Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity

16. Epidemiological, Clinical, and Phylogenetic Characteristics of the First SARS-CoV-2 Transmission in a Nursing Home of Singapore: A Prospective Observational Investigation

17. Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)

19. Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)

20. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing

22. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study

23. Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing

24. Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta).

25. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing.

26. Positive RT-PCR detected in patients recovered from COVID-19

27. Viral dynamics and immune correlates of COVID-19 disease severity

28. Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant

29. Clinical and Virological Features of SARS-CoV-2 Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)

30. Reducing spread of COVID-19 in closed environments: an outbreak investigation and modelling study in dormitory settings

32. Neutralizing antibodies from early cases of SARS-CoV-2 infection offer cross-protection against the SARS-CoV-2 D614G variant

33. Exportation of Monkeypox Virus From the African Continent

34. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2

35. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study

36. Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis

37. SARS-CoV-2 Infection among Travelers Returning from Wuhan, China

38. A Well Infant With Coronavirus Disease 2019 With High Viral Load

40. A COVID-19 Nursing Home Cluster Linked to a Household Transmission: An Epidemiological, Clinical and Phylogenetic Investigation

41. Association of SARS-CoV-2 Clades with Clinical, Inflammatory and Virologic Outcomes: An Observational Study

42. Immunological and Viral Correlates of COVID-19 Disease Severity: A Prospective Cohort Study of the First 100 Patients in Singapore

43. Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity.

44. Factors influencing SARS-CoV-2 transmission and outbreak control measures in densely populated settings.

45. Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore’s long term care facilities, 2017

47. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.

Catalog

Books, media, physical & digital resources